Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 AUD | -4.76% | -13.04% | -9.09% |
05-24 | PYC Therapeutics Secures US FDA Orphan Drug Designation for Eye Disease Medication Candidate; Shares Fall 4% | MT |
05-16 | PYC Therapeutics Completes Dosing for Eye Disease Trial; Shares Fall 5% | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.09% | 325M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- PYC Stock
- News PYC Therapeutics Limited
- Phylogica Announces Resignation of Sahm Nasseri from its Board of Directors